OBJECTIVE: Review current evidence on the role of fat in post-trauma insulin resistance, in reference to new studies with peroxisome proliferating activating receptor-alpha agonists. DESIGN: Review. SETTING: University laboratory. PATIENTS: Thirty pediatric burn trauma patients. INTERVENTIONS: Fourteen days of peroxisome proliferating activating receptor-alpha agonist immediately following burn trauma. MEASUREMENTS AND MAIN RESULTS: We measured glucose metabolism and fat metabolism via tracer methodology and intracellular measurements. Insulin-stimulated glucose uptake is impaired following burn trauma, as is intracellular insulin signaling, palmitate oxidation, and mitochondrial oxidative capacity. Furthermore, levels of intracellular lipids are increased. Two weeks of peroxisome proliferating activating receptor-alpha treatment significantly reverses these pathologic changes incurred from burn injury. CONCLUSIONS: Severe burn injury seriously affects multiple aspects of glucose and fat metabolism within the muscle, which can adversely affect clinical outcomes. Treatment with a peroxisome proliferating activating receptor-alpha drug may be a potential new therapeutic option.
OBJECTIVE: Review current evidence on the role of fat in post-trauma insulin resistance, in reference to new studies with peroxisome proliferating activating receptor-alpha agonists. DESIGN: Review. SETTING: University laboratory. PATIENTS: Thirty pediatric burn traumapatients. INTERVENTIONS: Fourteen days of peroxisome proliferating activating receptor-alpha agonist immediately following burn trauma. MEASUREMENTS AND MAIN RESULTS: We measured glucose metabolism and fat metabolism via tracer methodology and intracellular measurements. Insulin-stimulated glucose uptake is impaired following burn trauma, as is intracellular insulin signaling, palmitate oxidation, and mitochondrial oxidative capacity. Furthermore, levels of intracellular lipids are increased. Two weeks of peroxisome proliferating activating receptor-alpha treatment significantly reverses these pathologic changes incurred from burn injury. CONCLUSIONS: Severe burn injury seriously affects multiple aspects of glucose and fat metabolism within the muscle, which can adversely affect clinical outcomes. Treatment with a peroxisome proliferating activating receptor-alpha drug may be a potential new therapeutic option.
Authors: Sathish Babu Vasamsetti; Emilie Coppin; Xinyi Zhang; Jonathan Florentin; Sasha Koul; Matthias Götberg; Andrew S Clugston; Floyd Thoma; John Sembrat; Grant C Bullock; Dennis Kostka; Claudette M St Croix; Ansuman Chattopadhyay; Mauricio Rojas; Suresh R Mulukutla; Partha Dutta Journal: Sci Transl Med Date: 2020-07-22 Impact factor: 17.956
Authors: Melanie G Cree; Jennifer J Zwetsloot; David N Herndon; Bradley R Newcomer; Ricki Y Fram; Carlos Angel; Justin M Green; Gerald L Dohm; Dayoung Sun; Asle Aarsland; Robert R Wolfe Journal: J Burn Care Res Date: 2008 Jul-Aug Impact factor: 1.845
Authors: Juan-Pablo Idrovo; Jill A Shults; Brenda J Curtis; Michael M Chen; Elizabeth J Kovacs Journal: J Burn Care Res Date: 2019-10-16 Impact factor: 1.845
Authors: Nam K Tran; Zachary R Godwin; Amanda N Steele; Steven E Wolf; Tina L Palmieri Journal: Pediatr Crit Care Med Date: 2016-09 Impact factor: 3.624
Authors: Christian Sommerhalder; Elizabeth Blears; Andrew J Murton; Craig Porter; Celeste Finnerty; David N Herndon Journal: Curr Probl Surg Date: 2019-11-11 Impact factor: 1.909
Authors: Robert Kraft; David N Herndon; Celeste C Finnerty; Yaeko Hiyama; Marc G Jeschke Journal: J Clin Endocrinol Metab Date: 2012-11-12 Impact factor: 5.958